n-acetylglucopyranosylamine has been researched along with caffeine in 2 studies
*Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. [MeSH]
*Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. [MeSH]
| Studies (n-acetylglucopyranosylamine) | Trials (n-acetylglucopyranosylamine) | Recent Studies (post-2010) (n-acetylglucopyranosylamine) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
|---|---|---|---|---|---|
| 17 | 0 | 3 | 25,501 | 2,393 | 6,825 |
| Protein | Taxonomy | n-acetylglucopyranosylamine (IC50) | caffeine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 7.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, KR; Bichard, CJ; Fleet, GW; Johnson, LN; Kontou, M; Oikonomakos, NG; Watson, KA; Zographos, SE | 1 |
| Andersen, B; Westergaard, N | 1 |
2 other study(ies) available for n-acetylglucopyranosylamine and caffeine
| Article | Year |
|---|---|
N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
Topics: Animals; Binding Sites; Binding, Competitive; Caffeine; Crystallography, X-Ray; Drug Synergism; Enzyme Inhibitors; Glucosamine; Glucose; Kinetics; Models, Molecular; Molecular Structure; Phosphorylases; Rabbits; Ultracentrifugation | 1995 |
The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Topics: Amides; Animals; Arabinose; Caffeine; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Glucosamine; Glucose; Glycogen; Glycogen Phosphorylase; Hepatocytes; Imino Furanoses; Indoles; Inhibitory Concentration 50; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sugar Alcohols | 2002 |